Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV—Reply
JAMA Internal Medicine · 2024
DOI: 10.1001/jamainternmed.2024.0995 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Internal Medicine, 2024. Verfasst von Bruce Aldred und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
- The Ponce Center, Grady Health System, Atlanta, Georgia.
- Rollins School of Public Health, Emory University, Atlanta, Georgia.
Zitieren
APA
Aldred, B., Lyles, R. H., & Cantos, V. D. (2024). Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV—Reply. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2024.0995
Vancouver
Aldred B, Lyles RH, Cantos VD. Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV—Reply. JAMA Internal Medicine. 2024. doi:10.1001/jamainternmed.2024.0995
BibTeX
@article{Aldred2024,
author = {Aldred, Bruce and Lyles, Robert H and Cantos, Valeria D},
title = {Concerns With Analysis in Study of Tecovirimat for Mpox Among People With HIV—Reply},
journal = {JAMA Internal Medicine},
year = {2024},
doi = {10.1001/jamainternmed.2024.0995}
}
EUVIMED